Article
Amygdalin inhibits renal fibrosis in chronic kidney disease.
Molecular medicine reports - 1 May 2013
Guo Junqi, Wu Weizheng, Sheng Mingxiong, Yang Shunliang, Tan Jianming
Abstract excerpt
Renal interstitial fibrosis is a common outcome of chronic renal diseases. Amygdalin is one of a number of nitrilosides, the natural cyanide‑containing substances abundant in the seeds of plants of the prunasin family that are used to treat cancer and relieve pain. However, whether amygdalin inhibits the progression of renal fibrosis or not remains unknown. The present study aimed to assess the therapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
